Construction of a screening and evaluation system for anti-hepatitis B virus drugs based on quadratic exponential smoothing model

[1] Zhang, X., Liang, Y., Li, X., Wang, W., & Xu, Y. (2020). Clearance of hbsag in a patient with familial multiple myeloma after a bortezomib-based regimen combined with anti-hbv drug: a case report. Medicine, 99(40), e22642. Search in Google Scholar

[2] Olenginski, L. T., Kasprzak, W. K., Attionu, S. K., et al. (2023). Virtual Screening of Hepatitis B Virus Pre-Genomic RNA as a Novel Therapeutic Target. Molecules, 28(4), 1803. Search in Google Scholar

[3] Parvez, M. K., Al-Dosari, M. S., Abdelwahid, M. A. S., Alqahtani, A. S., & Alanzi, A. R. (2022). Novel anti-hepatitis b virus-active catechin and epicatechin from. Experimental and therapeutic medicine, 23(6), 398. Search in Google Scholar

[4] Zhu, S., Wen, H., Wang, W., et al. (2023). Anti-hepatitis B virus activity of lithospermic acid, a polyphenol from Salvia miltiorrhiza, in vitro and in vivo by autophagy regulation. Journal of Ethnopharmacology, 302, 115896. Search in Google Scholar

[5] A, S. A. B., A, Z. I. S., A, Z. A. P., B, A. S., A, M. A., & A, S. A. A., et al. (2022). Naturally occurring hmgb1 inhibitor delineating the anti-hepatitis b virus mechanism of glycyrrhizin via in vitro and in silico studies. Journal of Molecular Liquids. Search in Google Scholar

[6] Moharana, M., Pattanayak, S. K., Khan, F. (2022). Computational efforts to identify natural occurring compounds from phyllanthus niruri that target hepatitis B viral infections: DFT, docking and dynamics simulation study. Journal of the Indian Chemical Society, 99(9), 100662. Search in Google Scholar

[7] Hwang, N., Ban, H., Wu, S., et al. (2022). 4-Oxooctahydroquinoline-1 (2H)-carboxamides as hepatitis B virus (HBV) capsid core protein assembly modulators. Bioorganic & Medicinal Chemistry Letters, 58, 128518. Search in Google Scholar

[8] Ahmed, S., Parvez, M. K., Zia, K., et al. (2022). Natural anti-hepatitis B virus flavones isolated from stachys schimperi vatke growing in Saudi Arabia: Cell culture and molecular docking study. Pharmacognosy Magazine, 18(78), 386-392. Search in Google Scholar

[9] Fasola, F. A., Fowotade, A. A., Faneye, A. O., et al. (2022). Prevalence of hepatitis B virus core antibodies among blood donors in Nigeria: Implications for blood safety. African Journal of Laboratory Medicine, 11(1), 1-8. Search in Google Scholar

[10] Bernardino, J. I., & Arribas, J. R. (2017). Antiviral therapy. Infectious Diseases (Fourth Edition), 2, 918-926. Search in Google Scholar

[11] Ahn, S. M, Choi, J., Ye, B. D., et al. (2022). Risk of Hepatitis B virus (HBV) reactivation in patients with immune-mediated inflammatory diseases receiving biologics: focus on the timing of biologics after anti-HBV treatment. Gut and Liver, 16(4), 567. Search in Google Scholar

[12] Bahrami, A., Pourfathollah, A. A., Parsania, M., et al. (2022). Prevalence of occult hepatitis B virus infection among the blood donors in Golestan province: cross-sectional study. Iranian Journal of Microbiology, 14(3), 410-416. Search in Google Scholar

[13] Sa-Ngiamsuntorn, K., Thongsri, P., Pewkliang, Y., et al. (2022). A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target. JoVE (Journal of Visualized Experiments), (183), e63761. Search in Google Scholar

[14] Tan, S., Groaz, E., Kalkeri, R., et al. (2022). Reshaping an Acyclic Nucleoside Phosphonate into a Selective Anti-hepatitis B Virus Compound. Journal of Medicinal Chemistry, 65(13), 9396-9417. Search in Google Scholar

[15] Parvez, M. K., Al-Dosari, M. S., Rehman, M. T., et al. (2022). The anti-hepatitis B virus and anti-hepatotoxic efficacies of solanopubamine, a rare alkaloid from Solanum schimperianum. Saudi Pharmaceutical Journal, 30(4), 359-368. Search in Google Scholar

[16] Zhou, Q., Zhang, Q., Wang, K., et al. (2022). Anti-rheumatic drug-induced hepatitis B virus reactivation and preventive strategies for hepatocellular carcinoma. Pharmacological Research, 106181. Search in Google Scholar

[17] Papatheodoridis, G. V., Lekakis, V., Voulgaris, T., et al. (2022). Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators: A systematic review, meta-analysis, and expert opinion. Journal of Hepatology. Search in Google Scholar

[18] Inoue, T., Matsui, T., Tanaka, Y. (2021). Novel strategies for the early diagnosis of hepatitis B virus reactivation. Hepatology Research, 51(10), 1033-1043. Search in Google Scholar

[19] Singh, Uma, S., et al.(2018). 2′‐Fluoro‐6′‐methylene carbocyclic adenosine and its phosphoramidate prodrug: A novel anti‐HBV agent, active against drug‐resistant HBV mutants. Medicinal Research Reviews. Search in Google Scholar

[20] Wedemeyer, H., Schöneweis, K., Bogomolov, P., et al. (2023). Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial. The Lancet Infectious Diseases, 23(1), 117-129. Search in Google Scholar